News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Investor's Business Daily96d agobearish
Why Gilead's High-Profile HIV Drug Might Have To Play Catch-UpSimply Wall St.122d agobearish
Gilead Sciences (GILD) After Russell Growth Index Removal And A Fully Valued NarrativeBioPharma Dive166d agobearish
Astellas eyes more cost cuts; FDA panel to debate Moderna vaccineBarrons.com185d agobearish
Gilead Earnings Show HIV Drugs Continue to Shine. Why the Guidance Cut?Reuters185d agobearish
Gilead raises 2026 sales forecast, cuts profit outlook due to acquisitions